YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

New Alzheimer's drug approved in US

Posted online

U.S. regulators approved the first new treatment for Alzheimer's disease in nearly 20 years.

Biogen Inc.'s aducanumab medication is designed to target the underlying cause of Alzheimer's.

Scientists reportedly are divided over the treatment's potential impact due to uncertain trial results.

Read more from BBC News.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences